Literature DB >> 14763858

Development of a microscale cell culture analog to probe naphthalene toxicity.

Kwanchanok Viravaidya1, Aaron Sin, Michael L Shuler.   

Abstract

Prediction of human response to drugs or chemicals is difficult as a result of the complexity of living organisms. We describe an in vitro model that can realistically and inexpensively study the adsorption, distribution, metabolism, elimination, and potential toxicity (ADMET) of chemicals. A microscale cell culture analog (microCCA) is a physical replica of the physiologically based pharmacokinetics (PBPK) model. Such a microfabricated device consists of a fluidic network of channels to mimic the circulatory system and chambers containing cultured mammalian cells representing key functions of animal "organ" systems. This paper describes the application of a two-cell system, four-chamber microCCA ("lung"-"liver"-"other tissue"-"fat") device for proof-of-concept study using naphthalene as a model toxicant. Naphthalene is converted into reactive metabolites (i.e., 1,2-naphthalenediol and 1,2-naphthoquinone) in the "liver" compartment, which then circulate to the "lung" depleting glutathione (GSH) in lung cells. Such microfabricated in vitro devices are potential human surrogates for testing chemicals and pharmaceutics for toxicity and efficacy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14763858     DOI: 10.1021/bp0341996

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  62 in total

Review 1.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

2.  Building an experimental model of the human body with non-physiological parameters.

Authors:  Joseph M Labuz; Christopher Moraes; David R Mertz; Brendan M Leung; Shuichi Takayama
Journal:  Technology (Singap World Sci)       Date:  2017-03-31

Review 3.  Microscale technologies for tissue engineering and biology.

Authors:  Ali Khademhosseini; Robert Langer; Jeffrey Borenstein; Joseph P Vacanti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

Review 4.  Microfluidics for drug discovery and development: from target selection to product lifecycle management.

Authors:  Lifeng Kang; Bong Geun Chung; Robert Langer; Ali Khademhosseini
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

5.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

Review 6.  Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure.

Authors:  Jong Hwan Sung; Balaji Srinivasan; Mandy Brigitte Esch; William T McLamb; Catia Bernabini; Michael L Shuler; James J Hickman
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

7.  Exploitation of physical and chemical constraints for three-dimensional microtissue construction in microfluidics.

Authors:  Deepak Choudhury; Xuejun Mo; Ciprian Iliescu; Loo Ling Tan; Wen Hao Tong; Hanry Yu
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

8.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

Review 9.  Microfabricated mammalian organ systems and their integration into models of whole animals and humans.

Authors:  Jong H Sung; Mandy B Esch; Jean-Matthieu Prot; Christopher J Long; Alec Smith; James J Hickman; Michael L Shuler
Journal:  Lab Chip       Date:  2013-04-07       Impact factor: 6.799

Review 10.  Bioreactor engineering of stem cell environments.

Authors:  Nina Tandon; Darja Marolt; Elisa Cimetta; Gordana Vunjak-Novakovic
Journal:  Biotechnol Adv       Date:  2013-03-24       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.